Skip to main content

Pittsburgh biotech company wins funding for Covid-19 drug

CytoAgents received $250,000 from the Richard King Mellon Foundation to help develop its treatment for a side effect of the novel coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.